Not only that...there is a market cap benefit as the stock appreciates in response to the third party validation a partner brings to the science by making an investment in the product rather then on the arbitrage related to the stock.
Also... there is often a benefit in the potential shortening of timelines for further research with the added capital and research infrastructure a partner can bring.